Cabaletta Bio Launches Public Offering Of Stock And Warrants
12/6 03:23
(RTTNews) - Cabaletta Bio, Inc. (CABA), a clinical-stage biotech firm developing targeted cell therapies for autoimmune diseases, has initiated an underwritten public offering of its common stock and accompanying warrants....